S&P 500   4,205.45
DOW   33,093.34
QQQ   348.40
China's 1st domestically made passenger plane completes maiden commercial flight
[BREAKING] New "Living Missile" to Replace Nuclear Missiles (Ad)
In Nigeria’s hard-hit north, families seek justice as armed groups seek control
EgyptAir flight from Cairo blows tire during landing in Saudi Arabia
The Stock That's Brining Lithium Back To America! (Ad)
Russia launched 'largest drone attack' on Ukrainian capital before Kyiv Day; 1 killed
Stock market today: Asian markets mostly higher after Biden-McCarthy deal on US debt
The Stock That's Brining Lithium Back To America! (Ad)
Text released of 99-page bill to raise debt limit, curb spending; lawmakers to review as House eyes Wednesday vote
Takeaways on debt ceiling: McCarthy's balancing act, Biden's choice and the challenges ahead
S&P 500   4,205.45
DOW   33,093.34
QQQ   348.40
China's 1st domestically made passenger plane completes maiden commercial flight
[BREAKING] New "Living Missile" to Replace Nuclear Missiles (Ad)
In Nigeria’s hard-hit north, families seek justice as armed groups seek control
EgyptAir flight from Cairo blows tire during landing in Saudi Arabia
The Stock That's Brining Lithium Back To America! (Ad)
Russia launched 'largest drone attack' on Ukrainian capital before Kyiv Day; 1 killed
Stock market today: Asian markets mostly higher after Biden-McCarthy deal on US debt
The Stock That's Brining Lithium Back To America! (Ad)
Text released of 99-page bill to raise debt limit, curb spending; lawmakers to review as House eyes Wednesday vote
Takeaways on debt ceiling: McCarthy's balancing act, Biden's choice and the challenges ahead
S&P 500   4,205.45
DOW   33,093.34
QQQ   348.40
China's 1st domestically made passenger plane completes maiden commercial flight
[BREAKING] New "Living Missile" to Replace Nuclear Missiles (Ad)
In Nigeria’s hard-hit north, families seek justice as armed groups seek control
EgyptAir flight from Cairo blows tire during landing in Saudi Arabia
The Stock That's Brining Lithium Back To America! (Ad)
Russia launched 'largest drone attack' on Ukrainian capital before Kyiv Day; 1 killed
Stock market today: Asian markets mostly higher after Biden-McCarthy deal on US debt
The Stock That's Brining Lithium Back To America! (Ad)
Text released of 99-page bill to raise debt limit, curb spending; lawmakers to review as House eyes Wednesday vote
Takeaways on debt ceiling: McCarthy's balancing act, Biden's choice and the challenges ahead
S&P 500   4,205.45
DOW   33,093.34
QQQ   348.40
China's 1st domestically made passenger plane completes maiden commercial flight
[BREAKING] New "Living Missile" to Replace Nuclear Missiles (Ad)
In Nigeria’s hard-hit north, families seek justice as armed groups seek control
EgyptAir flight from Cairo blows tire during landing in Saudi Arabia
The Stock That's Brining Lithium Back To America! (Ad)
Russia launched 'largest drone attack' on Ukrainian capital before Kyiv Day; 1 killed
Stock market today: Asian markets mostly higher after Biden-McCarthy deal on US debt
The Stock That's Brining Lithium Back To America! (Ad)
Text released of 99-page bill to raise debt limit, curb spending; lawmakers to review as House eyes Wednesday vote
Takeaways on debt ceiling: McCarthy's balancing act, Biden's choice and the challenges ahead
Positive News SentimentPositive News
NASDAQ:LIVN

LivaNova (LIVN) Competitors

$44.02
-0.40 (-0.90%)
(As of 05/26/2023 08:47 PM ET)
Compare
Today's Range
$43.63
▼
$44.51
50-Day Range
$41.70
▼
$49.82
52-Week Range
$40.26
▼
$70.57
Volume
246,300 shs
Average Volume
503,060 shs
Market Capitalization
$2.37 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$64.60
ProfileAnalyst RatingsChartCompetitorsEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesOptions ChainSEC FilingsShort InterestSocial Media

LIVN vs. TMDX, ITGR, INMD, CNMD, OM, BLFS, MASI, PRVB, MORF, and CVAC

Should you be buying LivaNova stock or one of its competitors? The main competitors of LivaNova include TransMedics Group (TMDX), Integer (ITGR), InMode (INMD), CONMED (CNMD), Outset Medical (OM), BioLife Solutions (BLFS), Masimo (MASI), Provention Bio (PRVB), Morphic (MORF), and CureVac (CVAC). These companies are all part of the "medical" sector.

LivaNova vs.

LivaNova (NASDAQ:LIVN) and TransMedics Group (NASDAQ:TMDX) are both mid-cap medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their profitability, community ranking, media sentiment, valuation, earnings, dividends, risk, analyst recommendations and institutional ownership.

LivaNova has a net margin of -7.83% compared to TransMedics Group's net margin of -23.76%. LivaNova's return on equity of 10.40% beat TransMedics Group's return on equity.

Company Net Margins Return on Equity Return on Assets
LivaNova -7.83% 10.40% 5.54%
TransMedics Group -23.76% -18.30% -11.84%

TransMedics Group has lower revenue, but higher earnings than LivaNova. TransMedics Group is trading at a lower price-to-earnings ratio than LivaNova, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
LivaNova$1.02 billion2.32-$86.25 million-$1.54-28.58
TransMedics Group$93.46 million24.62-$36.23 million-$0.95-74.40

LivaNova received 294 more outperform votes than TransMedics Group when rated by MarketBeat users. Likewise, 69.57% of users gave LivaNova an outperform vote while only 53.24% of users gave TransMedics Group an outperform vote.

CompanyUnderperformOutperform
LivaNovaOutperform Votes
368
69.57%
Underperform Votes
161
30.43%
TransMedics GroupOutperform Votes
74
53.24%
Underperform Votes
65
46.76%

In the previous week, TransMedics Group had 3 more articles in the media than LivaNova. MarketBeat recorded 5 mentions for TransMedics Group and 2 mentions for LivaNova. LivaNova's average media sentiment score of 1.62 beat TransMedics Group's score of 0.85 indicating that LivaNova is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
LivaNova
1 Very Positive mention(s)
0 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Very Positive
TransMedics Group
2 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

LivaNova has a beta of 0.87, suggesting that its stock price is 13% less volatile than the S&P 500. Comparatively, TransMedics Group has a beta of 1.44, suggesting that its stock price is 44% more volatile than the S&P 500.

98.9% of LivaNova shares are owned by institutional investors. Comparatively, 88.6% of TransMedics Group shares are owned by institutional investors. 0.4% of LivaNova shares are owned by insiders. Comparatively, 6.7% of TransMedics Group shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.

LivaNova presently has a consensus price target of $64.60, indicating a potential upside of 46.75%. TransMedics Group has a consensus price target of $72.29, indicating a potential upside of 2.27%. Given LivaNova's higher possible upside, research analysts clearly believe LivaNova is more favorable than TransMedics Group.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
LivaNova
0 Sell rating(s)
2 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
2.50
TransMedics Group
0 Sell rating(s)
1 Hold rating(s)
6 Buy rating(s)
0 Strong Buy rating(s)
2.86

Summary

LivaNova beats TransMedics Group on 10 of the 18 factors compared between the two stocks.


New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding LIVN and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

LIVN vs. The Competition

Export to Excel
MetricLivaNovaElectromedical equipment IndustryMedical SectorNASDAQ Exchange
Market Cap$2.37B$3.29B$4.39B$6.16B
Dividend YieldN/A1.59%5.94%6.15%
P/E Ratio-28.589.36132.8214.49
Price / Sales2.3265.513,536.2686.88
Price / Cash6.9814.2391.70107.21
Price / Book1.934.544.997.14
Net Income-$86.25M$114.13M$116.26M$192.57M
7 Day Performance-3.76%-0.79%116.16%5.72%
1 Month Performance-8.10%-3.79%127.49%7.33%
1 Year Performance-34.81%8.42%133.28%-0.52%

LivaNova Competitors List

Export to Excel
CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
TMDX
TransMedics Group
1.2413 of 5 stars		$71.39
-4.1%		$72.29
+1.3%		+136.5%$2.32B$93.46M-75.15148Short Interest ↑
ITGR
Integer
2.141 of 5 stars		$79.97
-2.4%		$89.00
+11.3%		-0.1%$2.66B$1.38B39.3910,000Analyst Report
INMD
InMode
2.3439 of 5 stars		$34.15
-0.3%		$45.71
+33.9%		+20.9%$2.84B$454.27M16.99362Short Interest ↑
Positive News
CNMD
CONMED
1.9199 of 5 stars		$118.73
-1.5%		$128.00
+7.8%		N/A$3.63B$1.10B-41.814,100Dividend Announcement
OM
Outset Medical
1.4328 of 5 stars		$20.20
-8.6%		$24.50
+21.3%		-5.7%$994.45M$115.38M-5.72444
BLFS
BioLife Solutions
1.7529 of 5 stars		$22.26
+0.1%		$28.00
+25.8%		+52.7%$967.42M$161.76M-6.53432
MASI
Masimo
2.3727 of 5 stars		$155.24
-4.7%		$188.88
+21.7%		+9.7%$8.19B$2.04B71.216,000Short Interest ↑
PRVB
Provention Bio
2.0767 of 5 stars		$24.98
+3.1%		$22.83
-8.6%		+512.3%$2.37B$12.90M-16.3382Positive News
Gap Up
High Trading Volume
MORF
Morphic
1.9802 of 5 stars		$59.50
+4.3%		$70.33
+18.2%		+143.6%$2.36B$70.81M-36.28101Short Interest ↑
Positive News
CVAC
CureVac
1.9793 of 5 stars		$10.46
+8.2%		$21.00
+100.8%		-52.7%$2.34B$72.33M0.001,049Short Interest ↑
Gap Up

Related Companies and Tools

Related Companies:
Top 10 Stock Comparisons
This page (NASDAQ:LIVN) was last updated on 5/29/2023 by MarketBeat.com Staff

My Account -